Exclusive

Publication

Byline

Location

Andelyn Biosciences Selected To Manufacture Clinical Grade AAV Gene Therapy For Rare NKH Treatment

Singapore, Feb. 18 -- Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected by Drake Rayden Found... Read More


Lab discovery in New Zealand offers hope for lymphoedema treatment

Singapore, Feb. 18 -- Scientists at University of Auckland, New Zealand have made a breakthrough that could lead to effective treatments for lymphoedema, a painful swelling condition for which there i... Read More


Japan's Daiichi Sankyo collaborates with BostonGene to accelerate AI-based drug development

Singapore, Feb. 18 -- US-basedBostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced a strategic collaboration with Japanese pharmaceutical firmDaiic... Read More


Korean startup Galux raises $29 M to advance AI-driven protein design for drug discovery

Singapore, Feb. 17 -- Galux, a South Korea-based biotech startup pioneering artificial intelligence (AI)-driven protein therapeutics design, has announced the successful completion of a $29 million (K... Read More


QuidelOrtho enters strategic supply agreement to expand global immunoassay portfolio

Singapore, Feb. 16 -- QuidelOrtho has entered a long-term strategic supply agreement with China's Lifotronic Technology, to expand QuidelOrtho's global immunoassay portfolio and accelerate customer ac... Read More


Singapore's iX Biopharma secures $41 M contract from US govt for development of non-opioid pain treatment

Singapore, Feb. 16 -- Singapore-based iX Biopharma has been awarded a $40.95 million development contract by the United States Government to fund the development of Wafermine(R), its patented sublingu... Read More


Taiwan's PharmaEssentia invests $46 M to build manufacturing plant in Puerto Rico

Singapore, Feb. 16 -- PharmaEssentia Corporation, a global biopharmaceutical company headquartered in Taiwan with deep expertise in the development of novel biologics for hematology and oncology, and ... Read More


WHO prequalifies Biological E's oral polio vaccine

Singapore, Feb. 16 -- The World Health Organization (WHO) hasprequalified an additional novel oral polio vaccine type 2 (nOPV2), further strengthening the global supply of a vaccine at the heart of ef... Read More


Singapore presents holistic approach to stroke recovery aims to fast-track return to work for stroke survivors

Singapore, Feb. 16 -- An international study led by researchers from Singapore's National University Health System (NUHS) analyzed data from nearly 2,000 young stroke survivors under 50, finding that ... Read More


Australia's OncoRes Medical secures $27 M to advance real-time breast cancer surgery technology

Singapore, Feb. 13 -- Australia-based medtech innovator OncoRes Medical has secured $27 million in private funding, which will help progress clinical trials in breast cancer surgery using its world-cl... Read More